Microbia is an industrial biotechnology company applying proprietary metabolic engineering to create cost-effective, renewable specialty ingredients and biomaterials. Microbia will develop and commercialize its products through direct sales and strategic alliances, including an ongoing multi-product joint development and commercialization agreement with Tate & Lyle Investments, Ltd. Microbia's carotenoids will be the first products launched from a diverse pipeline of specialty ingredients, biopolymers and other biomaterials. Microbia was established in 2006 as a majority-owned subsidiary of Ironwood Pharmaceuticals, Inc. and is based in Lexington, Massachusetts.
View Top Employees from Microbia , Inc.| Website | http://www.microbia.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 1998 |
| Address | 60 Westview St, Lexington, Massachusetts 02421, US |
| Phone | (781) 259-7600 |
| Fax | (781) 862-0615 |
| Category | Biotechnology, Pharmaceuticals, Biopharma, Healthcare, Drug Manufacturing & Research, Health Care, Science and Engineering, Industrial |
| Competitors | Cidara Therapeutics, ConjuChem, Destiny Pharma plc, Gangagen Biotechnologies Bangalore(R&D), TSRL, Inc |
| SIC | 87, 873 |
| NAICS | 54171, 54, 5417, 541, 541713 |
Looking for a particular Microbia , Inc. employee's phone or email?
Microbia , Inc. Questions
The Microbia , Inc. annual revenue was $5 million in 2023.
Microbia , Inc. is based in Lexington, Massachusetts.
The NAICS codes for Microbia , Inc. are [54171, 54, 5417, 541, 541713].
The SIC codes for Microbia , Inc. are [87, 873].
